| Sunitinib malate for the treatment of pancreatic neuroendocrine tumors E Raymond, L Dahan, JL Raoul, YJ Bang, I Borbath, C Lombard-Bohas, ... New England Journal of Medicine 364 (6), 501-513, 2011 | 3090 | 2011 |
| FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer T Conroy, P Hammel, M Hebbar, M Ben Abdelghani, AC Wei, JL Raoul, ... New England Journal of Medicine 379 (25), 2395-2406, 2018 | 2659 | 2018 |
| Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer T Golan, P Hammel, M Reni, E Van Cutsem, T Macarulla, MJ Hall, ... New England Journal of Medicine 381 (4), 317-327, 2019 | 2251 | 2019 |
| Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised … JP Neoptolemos, DH Palmer, P Ghaneh, EE Psarelli, JW Valle, ... The Lancet 389 (10073), 1011-1024, 2017 | 2070 | 2017 |
| Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial C Louvet, R Labianca, P Hammel, G Lledo, MG Zampino, T André, ... Journal of Clinical Oncology 23 (15), 3509-3516, 2005 | 1263 | 2005 |
| Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib … P Hammel, F Huguet, JL van Laethem, D Goldstein, B Glimelius, P Artru, ... Jama 315 (17), 1844-1853, 2016 | 1113 | 2016 |
| Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone … B Chauffert, F Mornex, F Bonnetain, P Rougier, C Mariette, O Bouché, ... Annals of oncology 19 (9), 1592-1599, 2008 | 837 | 2008 |
| nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial D Goldstein, RH El-Maraghi, P Hammel, V Heinemann, V Kunzmann, ... Journal of the National Cancer Institute 107 (2), dju413, 2015 | 740 | 2015 |
| Risk of pancreatic adenocarcinoma in chronic pancreatitis D Malka, P Hammel, F Maire, P Rufat, I Madeira, F Pessione, P Levy, ... Gut 51 (6), 849-852, 2002 | 650 | 2002 |
| Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies F Huguet, T André, P Hammel, P Artru, J Balosso, F Selle, ... Journal of Clinical Oncology 25 (3), 326-331, 2007 | 643 | 2007 |
| Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct P Hammel, A Couvelard, D O'Toole, A Ratouis, A Sauvanet, JF Fléjou, ... New England Journal of Medicine 344 (6), 418-423, 2001 | 591 | 2001 |
| Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study J Edeline, M Benabdelghani, A Bertaut, J Watelet, P Hammel, JP Joly, ... Journal of Clinical Oncology 37 (8), 658-667, 2019 | 510 | 2019 |
| Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct B Terris, P Ponsot, F Paye, P Hammel, A Sauvanet, G Molas, P Bernades, ... The American journal of surgical pathology 24 (10), 1372-1377, 2000 | 495 | 2000 |
| Pancreatic involvement in von Hippel–Lindau disease PR Hammel, V Vilgrain, B Terris, A Penfornis, A Sauvanet, JM Correas, ... Gastroenterology 119 (4), 1087-1095, 2000 | 479 | 2000 |
| Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses M Voss, P Hammel, G Molas, L Palazzo, A Dancour, D O'toole, B Terris, ... Gut 46 (2), 244-249, 2000 | 478 | 2000 |
| Risk factors for diabetes mellitus in chronic pancreatitis D Malka, P Hammel, A Sauvanet, P Rufat, D O'Toole, P Bardet, J Belghiti, ... Gastroenterology 119 (5), 1324-1332, 2000 | 476 | 2000 |
| Assessment of complications of EUS-guided fine-needle aspiration D O'Toole, L Palazzo, R Arotçarena, A Dancour, A Aubert, P Hammel, ... Gastrointestinal endoscopy 53 (4), 470-474, 2001 | 461 | 2001 |
| Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial D Malka, P Cervera, S Foulon, T Trarbach, C de la Fouchardière, ... The lancet oncology 15 (8), 819-828, 2014 | 438 | 2014 |
| First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE … HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ... The Lancet Oncology 18 (9), 1159-1171, 2017 | 411 | 2017 |
| The natural history of hereditary pancreatitis: a national series V Rebours, MC Boutron-Ruault, M Schnee, C Férec, C Le Maréchal, ... Gut 58 (1), 97-103, 2009 | 380 | 2009 |
